Shamir Mehta

Shamir Mehta is a Professor of Medicine at McMaster University's Faculty of Health Sciences, holding the prestigious Douglas Holder Cardiology Chair. His clinical and research work is centered in the Department of Medicine with a primary focus on interventional cardiology and cardiovascular research. Dr. Mehta leads major international clinical trials that have significantly influenced global treatment guidelines for acute coronary syndromes and myocardial infarction management.

Dr. Mehta's research interests span interventional cardiology with particular emphasis on optimal revascularization strategies for ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease. His work has fundamentally shaped the understanding of complete versus culprit-only percutaneous coronary intervention approaches. He has pioneered research on antiplatelet therapy optimization, radiation safety in cardiac catheterization laboratories, and novel approaches to managing acute coronary syndromes across diverse patient populations. His research integrates clinical trials methodology with practical implementation science to bridge the gap between evidence and everyday practice.

Analysis of Dr. Mehta's recent publications (2019-2025) reveals a sustained focus on refining revascularization strategies for myocardial infarction, particularly the timing and extent of non-culprit lesion intervention. His work increasingly addresses personalized approaches to antiplatelet therapy and incorporates novel biomarkers for risk stratification. While maintaining his core focus on interventional cardiology, his research has expanded to address emerging challenges including cardiovascular aspects of the COVID-19 pandemic and hematological considerations in cardiac patients.

• Douglas Holder Cardiology Chair recipient

As principal investigator of landmark trials including COMPLETE, TRANSFER-AMI, and TOTAL, Dr. Mehta has secured substantial research funding that supports a large collaborative network across multiple countries. His work has directly influenced clinical practice guidelines worldwide, particularly regarding the management of STEMI with multivessel disease. He maintains active collaborations with cardiology research groups across North America, Europe, and Asia, facilitating multinational clinical trials that enroll thousands of patients annually.

Dr. Mehta leads the cardiovascular research program at McMaster, directing a team of clinical investigators, research coordinators, and data analysts focused on conducting high-quality randomized controlled trials in interventional cardiology. His laboratory focuses on translating clinical trial findings into practical implementation strategies for real-world settings, with particular attention to healthcare systems in both developed and developing countries.